Regencell Bioscience Holdings Ltd is an early-stage Traditional Chinese Medicine (TCM) bioscience company focused on research, development, and commercialization of TCM treatments for neurocognitive disorders, specifically Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD). The company is developing standardized liquid-based TCM formula candidates but has no approved products, no generated revenue, and no granted or pending patents. Operations have been funded primarily through proceeds from its initial public offering.
35 total filings indexed. 35 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001829667 |
| Ticker | RGC |
| Exchange | Nasdaq |
| SIC | 2833: Medicinal Chemicals & Botanical Products |
| Incorporated | E9 |
| Website | https://www.regencellbioscience.com |
| Listed | 2021-07-16 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/RGC (~200 tokens, structured JSON with cryptographic provenance)